Patent · US Active

Compounds and compositions for treating conditions associated with NLRP activity

US10654816B2 · kind B2 · utility

2Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2019
Grant dateMay 19, 2020
Priority date—
Expiry dateSep 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.